T. Haitjema

2.6k total citations · 1 hit paper
19 papers, 1.9k citations indexed

About

T. Haitjema is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, T. Haitjema has authored 19 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in T. Haitjema's work include Vascular Anomalies and Treatments (8 papers), Tracheal and airway disorders (6 papers) and Lung Cancer Treatments and Mutations (5 papers). T. Haitjema is often cited by papers focused on Vascular Anomalies and Treatments (8 papers), Tracheal and airway disorders (6 papers) and Lung Cancer Treatments and Mutations (5 papers). T. Haitjema collaborates with scholars based in Netherlands, United States and Switzerland. T. Haitjema's co-authors include Peter Heutink, Ben A. Oostra, Dorene S. Markel, Douglas A. Marchuk, David W. Johnson, E.A. Helmbold, Alan E. Guttmacher, Mary Kay McCormick, Mary Porteous and Charles E. Jackson and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer.

In The Last Decade

T. Haitjema

19 papers receiving 1.9k citations

Hit Papers

Endoglin, a TGF-β binding protein of endothelial cells, i... 1994 2026 2004 2015 1994 250 500 750 1000

Peers

T. Haitjema
T. Haitjema
Citations per year, relative to T. Haitjema T. Haitjema (= 1×) peers Cornelius J.J. Westermann

Countries citing papers authored by T. Haitjema

Since Specialization
Citations

This map shows the geographic impact of T. Haitjema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Haitjema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Haitjema more than expected).

Fields of papers citing papers by T. Haitjema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Haitjema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Haitjema. The network helps show where T. Haitjema may publish in the future.

Co-authorship network of co-authors of T. Haitjema

This figure shows the co-authorship network connecting the top 25 collaborators of T. Haitjema. A scholar is included among the top collaborators of T. Haitjema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Haitjema. T. Haitjema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ramaekers, Bram, Manuela Joore, Anne‐Marie C. Dingemans, et al.. (2019). Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study. Radiotherapy and Oncology. 144. 65–71. 11 indexed citations
2.
Ruysscher, Dirk De, Anne‐Marie C. Dingemans, J. Praag, et al.. (2018). Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non–Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study. Journal of Clinical Oncology. 36(23). 2366–2377. 75 indexed citations
3.
Ruysscher, Dirk De, Anne‐Marie C. Dingemans, J. Praag, et al.. (2017). MA 17.10 Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC. Journal of Thoracic Oncology. 12(11). S1874–S1875. 2 indexed citations
4.
Groen, Harry J.M., Anne‐Marie C. Dingemans, J. Belderbos, et al.. (2017). Prophylactic cranial irradiation (PCI) versus observation in radically treated stage III non-small cell lung cancer (NSCLC): A randomized phase III NVALT11 study.. Journal of Clinical Oncology. 35(15_suppl). 8502–8502. 3 indexed citations
5.
Mellema, Wouter W., Egbert F. Smit, Lizza Hendriks, et al.. (2015). Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer. Lung Cancer. 90(2). 249–254. 32 indexed citations
6.
Joerger, Markus, Sjaak A. Burgers, Paul Baas, et al.. (2011). Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first‐line platinum‐gemcitabine chemotherapy. Cancer. 118(9). 2466–2475. 57 indexed citations
7.
Annema, Jouke T., Sjaak A. Burgers, Marianne E. Smits, et al.. (2009). Implementation of endoscopic ultrasound for lung cancer staging. Gastrointestinal Endoscopy. 71(1). 64–70.e1. 28 indexed citations
8.
Mager, Johannes J., Pieter Zanen, Fred Verzijlbergen, et al.. (2002). Quantification of right-to-left shunt with 99mTc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. Clinical Science. 102(2). 127–134. 21 indexed citations
9.
Haitjema, T., et al.. (2001). Primary nasal tuberculosis.. PubMed. 39(1). 47–8. 22 indexed citations
10.
Haitjema, T., et al.. (1996). Epistaxis in hereditary haemorrhagic telangiectasia.. PubMed. 34(3). 176–8. 34 indexed citations
11.
Haitjema, T.. (1996). Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease). Archives of Internal Medicine. 156(7). 714–714. 85 indexed citations
12.
Haitjema, T., C. J. J. Westermann, Tim Th. C. Overtoom, et al.. (1996). Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment.. PubMed. 156(7). 714–9. 120 indexed citations
13.
Haitjema, T., F. J. M. Disch, Timotheus T. C. Overtoom, Cornelis J.J. Westermann, & Jan‐Willem J. Lammers. (1995). Screening family members of patients with hereditary hemorrhagic telangiectasia. The American Journal of Medicine. 99(5). 519–524. 126 indexed citations
14.
Haitjema, T., Tim Th. C. Overtoom, C. J. J. Westermann, & J.-W.J. Lammers. (1995). Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients.. Thorax. 50(7). 719–723. 96 indexed citations
15.
McAllister, Kimberly A., David W. Johnson, Carol J. Gallione, et al.. (1994). Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics. 8(4). 345–351. 1137 indexed citations breakdown →
16.
Haitjema, T., et al.. (1994). Pleural effusion without ascites in a patient with cirrhosis.. PubMed. 44(6). 207–9. 5 indexed citations
17.
Heutink, Peter, T. Haitjema, Guido J. Breedveld, et al.. (1994). Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity.. Journal of Medical Genetics. 31(12). 933–936. 59 indexed citations
18.
Cramer, Maarten J., et al.. (1994). Adrenal insufficiency secondary to postoperative bilateral adrenal haemorrhage.. PubMed. 45(1). 21–4. 4 indexed citations
19.
Haitjema, T., Heleen van Velzen‐Blad, & Jules M. van den Bosch. (1992). Extrinsic allergic alveolitis caused by goose feathers in a duvet.. Thorax. 47(11). 990–991. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026